Anifrolumab for Hidradenitis Suppurativa

Clinical trial NCT06374212 · COMPLETED

Trial details

NCT number: NCT06374212
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa Acne Inversa Hidradenitis

Start date: 2024-06-21
Primary completion: 2026-01-22
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.